Parkwalk News

12 November 2018

Parkwalk included in Global University Venturing 2018 Powerlist

By |November 12th, 2018|

Global University Venturing has just completed their inaugural Powerlist for 2018 based on their five-year data review of the university spin-out ecosystem earlier this year.

The data from the study showed Parkwalk as the world’s second most active investor in this sector, which can be seen here: Global investors in University spin-outs 2013 – 2017. Parkwalk […]

Duel – University of Bristol Enterprise Fund II investment

By |November 5th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Duel.

Duel is a centralised hub for managing Ambassador programs and all elements for Customer Advocacy Marketing for brands. It works by taking customers, turning them into advocates, then empowering these advocates to tell a brand’s story and rigorously track the results. […]

17 October 2018

Congenica – earns major role in supporting world’s first routine national genomic medicine service

By |October 17th, 2018|

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service

Cambridge, United Kingdom – 17 October, 2018 – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic […]

Oxbotica – appoints Fraser Robinson to drive global strategy

By |October 12th, 2018|

Oxbotica, the autonomous software company, today announces the appointment of Fraser Robinson to its board of directors. This follows Oxbotica’s recent completion of a £14 million investment which will support the next stage of its international development.

Robinson comes with a rare and proven track record, most recently leading Uber’s investment negotiations, strategy and partnerships […]

Vitamica – University of Bristol Enterprise Fund II investment

By |October 9th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Vitamica, a University of Bristol spin-out that aims to exploit a novel approach for determining the susceptibility of bacteria to antibiotics.

Resistance of bacteria to antibiotics is an increasing problem across the world, resulting in poorer healthcare […]

Paragraf – Large-scale production of graphene-based technologies

By |October 6th, 2018|

Paragraf, the Cambridge graphene start-up, has followed its seed investment of £2.9m, announced in May 2018, with the opening of a groundbreaking new facility

The site represents a turning point for graphene-based technologies, enabling Paragraf to drive large-scale development of mass-market, graphene-based electronic devices.

Paragraf’s proprietary production technique overcomes the quality, contamination and reproducibility barriers faced […]

Arkivum – Jersey Heritage contract

By |October 1st, 2018|

Jersey Heritage has chosen Arkivum Perpetua to store and preserve the huge volumes of digital records in its care. Holding the complete public record of States of Jersey, a photo archive of around 1.5 million images and digitised artefacts such as registration cards from the German occupation during World War Two, Jersey Heritage tells […]

27 September 2018

Healthera – UCEF V investment

By |September 27th, 2018|

We are delighted to announce that the University of Cambridge Enterprise Fund V has invested in a £3m Series A financing round into Healthera, a provider of next-generation, pharmacy-integrated personal health management solutions.

Healthera connects patients to a platform of hundreds of pharmacies and NHS GPs, allowing them to order and track prescriptions, access clinical […]

Oxbotica – Parkwalk investment

By |September 19th, 2018|

Oxbotica, the autonomous vehicle software company, today announces the completion of a £14 million investment to support the next stage of its growth strategy. Funds have been secured from three leading investors: IP Group plc, Parkwalk Advisors and AXA XL (formerly XL Catlin).

The investment will be used to further accelerate Oxbotica’s sustained growth, which […]

AudioTelligence – University of Cambridge Enterprise Fund V investment

By |September 18th, 2018|

We have recently made an investment in a £3.1m seed funding round in to AudioTelligence for the University of Cambridge Enterprise Fund V.

AudioTelligence is delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.

Speech control is being used increasingly in consumer electronics, with smart speakers being the world’s fastest-growing consumer […]

NuNano – University of Bristol Enterprise Fund II investment

By |September 18th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in NuNano.

NuNano specialise in the design of cantilever-based sensor devices and probes for atomic force microscopy. Microcantilevers are the simplest form of microelectromechanical systems (MEMS), which have come to prominence in the last decade or so. The basic […]

Exonate – University of Bristol Enterprise Fund II investment

By |September 17th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Exonate.

Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a protein called Vascular Endothelial Growth Factor (VEGF), they have demonstrated that they could not only treat models […]

Lettus Grow – University of Bristol Enterprise Fund II investment

By |September 1st, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Lettus Grow.

Lettus Grow is a Bristol-based company supported by the award winning SETSquared incubator and the Oracle Global Cloud Accelerator. The company has developed a novel irrigation system to increase productivity in food production, with early […]

28 August 2018

Arago Bioscience – University of Oxford Innovation Fund IV investment

By |August 28th, 2018|

We are delighted to announce that the University of Oxford Innovation Fund IV has invested in Arago Biosciences alongside Oxford Sciences Innovation. Arago has designed the world’s most sensitive light microscope.

Arago Biosciences, a spin-out company from the University of Oxford’s Department of Chemistry, has designed a new way of detecting and quantifying molecules. The […]

Astellas announces acquisition of Quethera

By |August 10th, 2018|

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma.

Through this transaction, Astellas has acquired Quethera’s ophthalmic gene therapy program, which uses a recombinant adeno-associated viral vector system (rAAV) to introduce […]

University of Cambridge Enterprise Fund VI launched

By |August 3rd, 2018|

Parkwalk are delighted to announce the launch of the University of Cambridge Enterprise Fund VI.

Launched in conjunction with Cambridge Enterprise, the University’s Technology Transfer and academic consulting subsidiary, the University of Cambridge Enterprise Funds offer alumni and investors the opportunity to invest in companies formed to develop and commercialise technology and intellectual property developed at the University of Cambridge in […]

Ilika – Parkwalk investment

By |August 1st, 2018|

We are delighted to announce that the Parkwalk Opportunities EIS Fund has participated in a £4.4m funding round in Ilika, an AIM listed company which specialises in materials innovation. The company has developed unique solid state battery technology which may have applications across the Internet of Things (IoT).

Ilika spun out of the University of […]

30 July 2018

AQDOT – Follow on Investment

By |July 30th, 2018|

We have recently made a follow-on investment into Aqdot on behalf of the Parkwalk Opportunities EIS Fund.

Aqdot is a spin-out from the Department of Chemistry at the University of Cambridge and was founded in late 2012. Its proprietary technology introduces an innovative, simple method for manufacturing structures in the millimetre and nanometre range that are […]

Proxisense – Parkwalk closes investment

By |July 23rd, 2018|

We are delighted to announce that the Parkwalk Opportunities Fund has invested in Proxisense, an Oxford University spinout supplying specialised proximity sensors and systems to measure contamination in critical fluid systems. These products have been developed for use is for extreme and inaccessible environments.

The proximity sensor technology utilises an eddy current sensor and enables […]

Bramble Energy – Parkwalk investment

By |July 20th, 2018|

We have recently closed an investment in Bramble Energy , a UCL and Imperial College London spinout which has developed a unique, patent protected, printed circuit board (PCB) fuel cell – the PCBFC™.

The PCBFC™ utilises cost-effective production methods and materials from the PCB industry to reduce the cost and complexity of manufacturing of proton exchange […]